Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001641172-25-022600
Filing Date
2025-08-07
Accepted
2025-08-07 16:50:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 14654
2 EX-1 ex1.htm EX-1 11270
  Complete submission text file 0001641172-25-022600.txt   27784
Mailing Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022 2128473500
GOLDENTREE ASSET MANAGEMENT LP (Filed by) CIK: 0001278951 (see all company filings)

EIN.: 134118850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D

Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15 353 1 6960000
Mallinckrodt plc (Subject) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | State of Incorp.: L2 | Fiscal Year End: 1226
Type: SCHEDULE 13D | Act: 34 | File No.: 005-87833 | Film No.: 251194997
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)